1460775400-de95e03d-63fe-4c42-97dc-3c4cb0691bc3

1. An apparatus for use in treating a hollow anatomical structure (HAS), the apparatus comprising:
an elongate member having a distal section and a proximal section, the elongate member being sized for insertion into a HAS;
a treating element located on the elongate member and having a first length;
wherein the treating element has a distal section and a proximal section and is configured to apply energy along a length of the HAS in consecutive treatment segments of the HAS;

a plurality of index markings marked on the elongate member;
wherein the index markings are configured to be movably indexed in a distal to proximal direction via movement of the elongate member in the distal to proximal direction to sequentially position the treating element axially along the length of the HAS;

at least one final marking marked on the elongate member that indicates a final distance from said final marking to the proximal section of the treating element; and
a warning section marked on the elongate member, the warning section comprising a distinct marking different from the plurality of index markings and the at least one final marking;
wherein consecutive index markings are spaced apart by a second length, the second length being less than the first length to ensure overlap of consecutive treated segments of the HAS when the treating element is moved in the distal to proximal direction along the HAS.
2. The apparatus of claim 1, wherein the warning section is located on the elongate member proximal of the at least one final marking.
3. The apparatus of claim 1, wherein the warning section is between the plurality of index markings and the at least one final marking.
4. An apparatus for treating a hollow anatomical structure (HAS), the apparatus comprising:
an elongate member having a distal section and a proximal section;
a treating element on the elongate member and having a distal section and a proximal section;
wherein the treating element has a first length;

a plurality of index markings marked on the elongate member;
wherein consecutive index markings are spaced apart by a second length, the second length being less than the first length to ensure overlap of consecutive treated segments of the HAS;

at least one final marking marked on the elongate member that indicates a final treatment position of the treating element; and
a warning section marked on the elongate member, wherein the warning section comprises a distinct marking different from the plurality of index markings and the at least one final marking.
5. The apparatus of claim 4, wherein the warning section is located on the elongate member proximal of the at least one final marking.
6. The apparatus of claim 4, wherein the warning section is between the plurality of index markings and the at least one final marking.
7. An apparatus for treating a hollow anatomical structure (HAS), the apparatus comprising:
an elongate member having a distal section and a proximal section;
a treating element located on the elongate member and having a distal section, a proximal section, and a first length;
a plurality of index markings marked on the elongate member, consecutive index markings being spaced apart by a second length;
at least one final marking marked on the elongate member to indicate a final distance from said final marking to the proximal section of the treating element; and
a warning section marked on the elongate member, the warning section comprising a distinct marking different from the plurality of index markings and the at least one final marking.
8. The apparatus of claim 7, wherein the warning section is located on the elongate member proximal of the at least one final marking.
9. The apparatus of claim 7, wherein the warning section is between the plurality of index markings and the at least one final marking.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A method for detecting in a DNA duplex, a mismatch resulting from a base substitution, or from insertion or deletion of one or more nucleotides in one strand of said duplex wherein said method comprises:
incubating said duplex with a recombinant BFN1 endonuclease having the following mismatch preference: GG\u02dcGA\u02dcAG\u02dcGT\u02dcTG>TT\u02dcAA\u02dcCC\u02dcTC>CT\u02dcAC\u02dcCA, wherein said BFN1 endonuclease cleaves said duplex if at least one of said mismatches is present;
analysing the cleavage products.
2. The method of claim 1, wherein the recombinant BFN1 endonuclease is able to recognize a mutant allele in the presence of a 59-fold excess of the wild type allele.
3. The method of claim 1, wherein the recombinant BFN1 endonuclease is produced by a method comprising:
expressing said recombinant endonuclease in cells of a host plant, transiently transformed with an Agrobacterium strain containing an expression vector comprising a polynucleotide encoding said endonuclease;
isolating said recombinant BFN1 endonuclease from said host plant cells.
4. A method of claim 1, which is used in a Targeting-Induced Local Lesions IN Genomes (TILLING) mismatch cleavage protocol.
5. A method of claim 1, which is used for the identification of DNA polymorphisms in natural populations, by Ecotilling.
6. A method of claim 1, which is used for simultaneously screening one or more mutations in a target gene in a population of any organism or cell-line derived therefrom, by performing the steps of:
a) amplifying said target gene or part thereof for each individual of said population,
b) ordering said amplifications product in a 2- or 3-dimensional matrix, comprising lines, rows (2-D matrix) and columns (3-D matrix),
c) pooling said amplification products such as to obtain different pools, each pool representing a row, a line or a column of said matrix,
d) adding to each pool a reference amplification product obtained from a non-mutated gene, and incubating such pools in conditions permitting formation of heteroduplexes, and
e) incubating each pool with said recombinant BFN 1 endonuclease, and
f) detecting the presence of heteroduplexes in said incubated pools.
7. A method of claim 1, which is used for simultaneously screening one or more mutations in a target gene in a population of any organism or cell-line derived therefrom, by performing the steps of:
a) ordering each individuals of said population, in a 2- or 3-dimensional matrix, comprising lines, rows (2-D matrix) and columns (3-D matrix),
b) pooling each row, line and column in order to obtain different pools, each pool thus representing a row, a line or a column of said matrix,
c) adding to each pool a reference gene product obtained from a non-mutated gene,
d) amplifying said target gene or part thereof in each pool in order to get pools of amplified products,
e) incubating said pools of amplified products in conditions permitting formation of heteroduplexes,
f) incubating said pools of amplified products with said recombinant BFN 1 preparation, and
g) detecting the presence of heteroduplexes in said incubated pools.